Enliven Therapeutics, Inc.
ELVNNASDAQHealthcareBiotechnology
$37.32Today:- (-)1Y +83.70%
As of Oct 16, 2026 close
- Market cap
- $2.60B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $14.79$62.32
- Volume (live)
- -
- Avg. volume (3M)
- 1.45M
Enliven Therapeutics, Inc. (ELVN) Dividends
Enliven Therapeutics, Inc. does not currently pay dividends, or its dividend history is not available.